Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 9423677)

1.

Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging.

Lang P, Wendland MF, Saeed M, Gindele A, Rosenau W, Mathur A, Gooding CA, Genant HK.

Radiology. 1998 Jan;206(1):227-35.

PMID:
9423677
2.

Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.

Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M.

Invest Radiol. 2006 Aug;41(8):618-23.

PMID:
16829744
3.

Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.

Thoeny HC, De Keyzer F, Chen F, Ni Y, Landuyt W, Verbeken EK, Bosmans H, Marchal G, Hermans R.

Radiology. 2005 Mar;234(3):756-64.

PMID:
15734932
4.

Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.

Bartolozzi C, Lencioni R, Caramella D, Mazzeo S, Ciancia EM.

AJR Am J Roentgenol. 1994 Apr;162(4):827-31.

PMID:
8141000
5.

Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.

Uhl M, Saueressig U, Koehler G, Kontny U, Niemeyer C, Reichardt W, Ilyasof K, Bley T, Langer M.

Pediatr Radiol. 2006 Dec;36(12):1306-11. Epub 2006 Oct 10.

PMID:
17031633
6.

Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization.

Castrucci M, Sironi S, De Cobelli F, Salvioni M, Del Maschio A.

Abdom Imaging. 1996 Nov-Dec;21(6):488-94.

PMID:
8875869
7.

Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.

Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD.

Invest Radiol. 1992 May;27(5):367-73.

PMID:
1582820
8.

Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.

Razek AA, Megahed AS, Denewer A, Motamed A, Tawfik A, Nada N.

Acta Radiol. 2008 Apr;49(3):364-70. doi: 10.1080/02841850701777390.

PMID:
18365828
9.

Depiction of reperfused myocardial infarction using contrast-enhanced spin echo and gradient echo magnetic resonance imaging.

Geschwind JF, Saeed M, Wendland MF, Higgins CB.

Invest Radiol. 1998 Jul;33(7):386-92.

PMID:
9659590
10.

Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.

Yasumoto M, Shibuya H, Takeda M, Korenaga T.

AJR Am J Roentgenol. 1995 Apr;164(4):981-7.

PMID:
7726062
11.

Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging.

Thoeny HC, De Keyzer F, Vandecaveye V, Chen F, Sun X, Bosmans H, Hermans R, Verbeken EK, Boesch C, Marchal G, Landuyt W, Ni Y.

Radiology. 2005 Nov;237(2):492-9. Epub 2005 Sep 28.

PMID:
16192323
12.

Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent Gadophrin-3.

Metz S, Daldrup-Unk HE, Richter T, Räth C, Ebert W, Settles M, Rummeny EJ, Link TM, Piert M.

Acad Radiol. 2003 May;10(5):484-90.

PMID:
12755535
13.

Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings.

Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, Budinsky L, Jellus V, Osteaux M.

AJNR Am J Neuroradiol. 2001 May;22(5):969-76.

14.

Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy.

Torricelli P, Montanari N, Spina V, Manfrini M, Bertoni F, Saguatti G, Romagnoli R.

Radiol Med. 2001 Mar;101(3):145-51.

PMID:
11402952
15.

Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?

Vliegen RF, Beets GL, von Meyenfeldt MF, Kessels AG, Lemaire EE, van Engelshoven JM, Beets-Tan RG.

Radiology. 2005 Jan;234(1):179-88. Epub 2004 Nov 18.

PMID:
15550372
16.

Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.

Low RN, Francis IR, Herfkens RJ, Jeffrey RB Jr, Glazer GM, Foo TK, Shimakawa A, Pelc NJ.

AJR Am J Roentgenol. 1993 Mar;160(3):501-9.

PMID:
8381572
17.

MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model.

Lee SS, Goo HW, Park SB, Lim CH, Gong G, Seo JB, Lim TH.

Radiology. 2003 Mar;226(3):739-47. Epub 2003 Jan 24. Erratum in: Radiology. 2003 Nov;229(2):610.

PMID:
12601203
18.

Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.

Worawattanakul S, Semelka RC, Noone TC, Calvo BF, Kelekis NL, Woosley JT.

Magn Reson Imaging. 1998 Nov;16(9):993-1003.

PMID:
9839983
19.

Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.

Kubota T, Yamada K, Kizu O, Hirota T, Ito H, Ishihara K, Nishimura T.

J Magn Reson Imaging. 2005 Jun;21(6):694-700.

PMID:
15906343
20.

Dysprosium-enhanced MR imaging for tumor tissue characterization. An experimental study in a human xenograft model.

Wang C, Sundin A, Ericsson A, Bach-Gansmo T, Hemmingsson A, Ahlström H.

Acta Radiol. 1997 Mar;38(2):281-6.

PMID:
9093166
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk